Research Article

Combined Treatment of Adipose Derived-Mesenchymal Stem Cells and Pregabalin Is Superior to Monotherapy for the Treatment of Neuropathic Pain in Rats

Figure 2

Sciatic function index (SFI) on day 21 posttreatment. The injured group showed deterioration of the SFI compared to the sham group. All treated groups showed significant improvement in the SFI ( vs. sham, #injured, @adipose tissue-derived mesenchymal stem cells (ADMSCs), ^pregabalin, or $combined). The combined treatment showed a highly significant improvement in SFI compared to pregabalin, but not ADMSCs alone ().